FDA Is Launching Real-Time Monitoring of Drug Trials, with AstraZeneca and Amgen as First Test Cases

FDA launches effort to speed up clinical trials, using AI

FDA announces cancer drug trials by AstraZeneca and Amgen will be monitored in real time, a test of how to shorten time interval between trial phases.

FDA is launching real-time monitoring of drug trials, with AstraZeneca and Amgen as first test cases

The agency says 45% of drug development time is currently "dead time" — real-time data access could cut months or years from the process

Amgen, Astra launch real-time trials as part of FDA pilot

Amgen (AMGN) and AstraZeneca (AZN) begin real-time clinical trials as the FDA plans to launch a pilot to accelerate drug development using AI. Read more here.

FDA Announces Major Steps to Implement Real-Time Clinical Trials

White Oak, Md., April 28, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced two major steps as part of an initiative to advance the implementation of real-time clinical trials (RTCT). First, the agency unveiled the successful…

FDA Unveils Roadmap for Real-Time Clinical Evidence

The U.S. Food and Drug Administration announced two major steps as part of an initiative to advance the implementation of real-time clinical trials (RTCT). Image for illustration purposes Texas Border Business U.S. Food and Drug Administration The U.S. Food and Drug Administration announced two major steps as part of an initiative to advance the implementation of real-time clinical trials (RTCT). First, the agency unveiled the successful initiat…

FDA announces real-time clinical trial data effort, with AstraZeneca and Amgen as test cases

The FDA is launching a pilot program to collect and review clinical trial data in real time, giving scientific reviewers access to the data as it flows in, the agency announced Tuesday. AstraZeneca and Amgen ...